Liposomal vincristine in relapsed non-Hodgkin's lymphomas: Early results of an ongoing phase II trial
Open Access
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (1) , 69-72
- https://doi.org/10.1023/a:1008348010437
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The binding of vincristine, vinblastine and colchicine to tubulinPublished by Elsevier ,2004
- Phase I Study of Liposomal VincristineJournal of Clinical Oncology, 1999
- Liposome encapsulated vincristine: preclinical toxicologic and pharmacologic comparison with free vincristine and empty liposomes in mice, rats and dogsAnti-Cancer Drugs, 1994
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]Blood, 1994
- Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomasCancer, 1994
- Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemiaCancer Chemotherapy and Pharmacology, 1993
- Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.Journal of Clinical Oncology, 1991
- Twenty years of MOPP therapy for Hodgkin's disease.Journal of Clinical Oncology, 1986
- Treatment of advanced non-Hodgkin's lymphoma with vincristine infusionCancer, 1984
- A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.Journal of Clinical Oncology, 1983